How Metformin Works—and Why It Does Far More Than Expected

A Medieval Plant, a Modern Wonder Drug

Metformin is the most prescribed diabetes medication on Earth, taken by roughly 150 million people worldwide. It costs pennies per pill, has been used clinically since 1957, and traces its origins to a flowering plant called Galega officinalis—known as French lilac or goat's rue—used in medieval Europe to relieve symptoms of what we now call diabetes.

Yet after nearly seven decades of clinical use, scientists are still discovering new things metformin can do. Beyond controlling blood sugar, it is now being investigated as a potential weapon against cancer, cardiovascular disease, Alzheimer's, and even aging itself.

From Flower to Pharmacy

In the mid-1800s, chemists found that Galega officinalis was rich in guanidine, a compound that lowers blood glucose. Guanidine derivatives were tested on diabetic patients in the 1920s but abandoned due to toxicity. Metformin—a dimethylbiguanide—was synthesized during that era but overlooked until the 1940s, when researchers studying antimalarial agents noticed it lowered blood sugar during clinical tests for influenza.

French physician Jean Sterne championed metformin for diabetes treatment in 1957, coining the brand name Glucophage—literally "glucose eater." It took until 1995 for the U.S. FDA to approve it, but metformin quickly became the first-line therapy for type 2 diabetes recommended by guidelines worldwide.

How It Actually Works

Despite its long history, metformin's precise mechanisms remain surprisingly debated. Scientists have identified several overlapping pathways:

• Mitochondrial complex I inhibition — Metformin dials down the mitochondrial respiratory chain, reducing the cell's ability to produce energy from glucose, which in turn lowers blood sugar.
• AMPK activation — It switches on AMP-activated protein kinase, the cell's master energy sensor, which boosts glucose uptake and fatty acid oxidation.
• Liver glucose suppression — It cuts hepatic glucose production, the main reason fasting blood sugar drops.
• Gut microbiome effects — A surprising finding: metformin alters intestinal bacteria composition in ways that independently improve metabolism. Studies show that a gut-only formulation with minimal systemic absorption can still lower blood glucose.

This multiplicity of mechanisms is precisely what makes metformin so intriguing to researchers looking beyond diabetes.

The Expanding Frontier

Metformin is now under investigation for a remarkable range of conditions. Observational studies have linked it to reduced cancer incidence among diabetic patients, likely through inhibition of the mTOR signaling pathway that drives cell growth. It is used off-label for polycystic ovary syndrome (PCOS), where it helps restore ovulation. Researchers are also exploring its potential in cardiovascular protection, non-alcoholic fatty liver disease, and even neurodegenerative conditions like Alzheimer's.

A recent clinical trial found that metformin can help people with type 1 diabetes—a condition where it is not traditionally prescribed—use roughly 12% less insulin while maintaining stable blood sugar, according to ScienceDaily.

Could It Slow Aging?

The boldest claim about metformin is that it might slow biological aging itself. The TAME trial (Targeting Aging with Metformin), led by Dr. Nir Barzilai at the Albert Einstein College of Medicine, aims to enroll 3,000 adults aged 65–79 to test whether metformin delays a cluster of age-related diseases—cancer, heart disease, cognitive decline, and death—as a group.

Research published in Signal Transduction and Targeted Therapy has shown metformin decelerates biomarkers tracked by aging clocks, epigenetic measurements that estimate biological age. If the TAME trial confirms these findings, metformin could become the first FDA-approved drug that targets aging as a medical condition.

Cheap, Safe, and Still Surprising

Metformin's safety profile is well established after decades of use. Side effects—mainly gastrointestinal—are usually mild and temporary. Its most serious risk, lactic acidosis, is extremely rare. At a cost often below $10 per month in generic form, it remains one of the most cost-effective drugs in medicine.

What makes metformin extraordinary is not any single breakthrough but its stubborn refusal to fit into one box. A molecule derived from a medieval folk remedy continues to challenge what modern medicine thinks a single drug can do—and scientists are still mapping the full extent of its reach.